Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease
Evangelia Makri, Antonis Goulas, Stergios A. Pοlyzos
Topics & Concepts
MedicineNonalcoholic fatty liver diseaseSteatosisCirrhosisInternal medicineGastroenterologyDiabetes mellitusPopulationType 2 diabetesFibrosisClinical trialHepatocellular carcinomaChronic liver diseaseFatty liverDiseaseEndocrinologyEnvironmental healthLiver Disease Diagnosis and TreatmentPancreatitis Pathology and TreatmentDrug Transport and Resistance Mechanisms